HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels

HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels

Background/aim: Direct-acting antivirals (DAAs) have improved the treatment of HCV-positive kidney transplant recipients (KTRs). However, their medium-term follow-up effects on graft function are conflicting. This study aimed to analyze how the interplay between DAAs, calcineurin inhibitors (CNI), a...

Full description

Bibliographic Details
Main Authors: Maria Rendina, Ernesto Paoletti, Nunzia Labarile, Antonella Marra, Andrea Iannone, Antonino Castellaneta, Elisabetta Bussalino, Maura Ravera, Antonio Schena, Nicola M. Castellaneta, Michele Barone, Simona Simone, Loreto Gesualdo, Alfredo Di Leo
Format: Article
Language:English
Published: SAGE Publishing 2022-09-01
Series:Therapeutic Advances in Chronic Disease
Online Access:https://doi.org/10.1177/20406223221117975

Internet

https://doi.org/10.1177/20406223221117975

Similar Items